{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,26]],"date-time":"2026-09-26T05:14:02Z","timestamp":1790399642098,"version":"4.1.0"},"reference-count":77,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2015,1,1]],"date-time":"2015-01-01T00:00:00Z","timestamp":1420070400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100003329","name":"Spanish Ministerios de Econom\u00eda y Competitividad","doi-asserted-by":"crossref","award":["SAF2013-48532-R"],"award-info":[{"award-number":["SAF2013-48532-R"]}],"id":[{"id":"10.13039\/501100003329","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Sanidad Pol\u00edtica Social e Igualdad","award":["PNSD #2012\/071"],"award-info":[{"award-number":["PNSD #2012\/071"]}]},{"name":"Sanidad Pol\u00edtica Social e Igualdad","award":["ISCIII, CIBERNED CB06\/05\/0055"],"award-info":[{"award-number":["ISCIII, CIBERNED CB06\/05\/0055"]}]}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neurobiology of Disease"],"published-print":{"date-parts":[[2015,1]]},"DOI":"10.1016\/j.nbd.2014.09.010","type":"journal-article","created":{"date-parts":[[2014,10,1]],"date-time":"2014-10-01T01:23:32Z","timestamp":1412126612000},"page":"49-59","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":71,"special_numbering":"C","title":["Nitric oxide synthase inhibition decreases l-DOPA-induced dyskinesia and the expression of striatal molecular markers in Pitx3\u2212\/\u2212 aphakia mice"],"prefix":"10.1016","volume":"73","author":[{"given":"Oscar","family":"Sol\u00eds","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Isabel","family":"Espadas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elaine A.","family":"Del-Bel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rosario","family":"Moratalla","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.nbd.2014.09.010_bb0005","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1006\/nbdi.1999.0259","article-title":"Striatal fosB expression is causally linked with l-DOPA-induced abnormal involuntary movements and the associated upregulation of striatal prodynorphin mRNA in a rat model of Parkinson's disease","volume":"6","author":"Andersson","year":"1999","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.nbd.2014.09.010_bb0010","doi-asserted-by":"crossref","first-page":"1066","DOI":"10.1038\/npp.2013.307","article-title":"Methamphetamine causes degeneration of dopamine cell bodies and terminals of the nigrostriatal pathway evidenced by silver staining","volume":"39","author":"Ares-Santos","year":"2014","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.nbd.2014.09.010_bb0015","doi-asserted-by":"crossref","first-page":"1710","DOI":"10.1038\/npp.2008.228","article-title":"Histone H3 phosphorylation is under the opposite tonic control of dopamine D2 and adenosine A2A receptors in striatopallidal neurons","volume":"34","author":"Bertran-Gonzalez","year":"2009","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.nbd.2014.09.010_bb0020","doi-asserted-by":"crossref","first-page":"1043","DOI":"10.1111\/j.1471-4159.2011.07376.x","article-title":"Amantadine attenuates levodopa-induced dyskinesia in mice and rats preventing the accompanying rise in nigral GABA levels","volume":"118","author":"Bido","year":"2011","journal-title":"J. Neurochem."},{"key":"10.1016\/j.nbd.2014.09.010_bb0025","first-page":"639080","article-title":"Dyskinesia in Parkinson's disease therapy","volume":"2012","author":"Carta","year":"2012","journal-title":"Park. Dis."},{"key":"10.1016\/j.nbd.2014.09.010_bb0030","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/S0079-6123(10)83011-0","article-title":"Maladaptive striatal plasticity in L-DOPA-induced dyskinesia","volume":"183","author":"Cenci","year":"2010","journal-title":"Prog. Brain Res."},{"key":"10.1016\/j.nbd.2014.09.010_bb0035","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1016\/S0306-4522(99)00294-8","article-title":"Changes in the regional and compartmental distribution of FosB- and JunB-like immunoreactivity induced in the dopamine-denervated rat striatum by acute or chronic L-dopa treatment","volume":"94","author":"Cenci","year":"1999","journal-title":"Neuroscience"},{"key":"10.1016\/j.nbd.2014.09.010_bb0040","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1016\/j.neuint.2007.02.002","article-title":"The effect of subchronic, intermittent L-DOPA treatment on neuronal nitric oxide synthase and soluble guanylyl cyclase expression and activity in the striatum and midbrain of normal and MPTP-treated mice","volume":"50","author":"Chalimoniuk","year":"2007","journal-title":"Neurochem. Int."},{"key":"10.1016\/j.nbd.2014.09.010_bb0050","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1016\/j.neuropharm.2012.12.010","article-title":"Morphine withdrawal produces ERK-dependent and ERK-independent epigenetic marks in neurons of the nucleus accumbens and lateral septum","volume":"70","author":"Ciccarelli","year":"2013","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.nbd.2014.09.010_bb0055","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1016\/j.brainres.2013.10.011","article-title":"Alterations in the expression of nNOS in the substantia nigra and subthalamic nucleus of 6-OHDA-lesioned rats: the effects of chronic treatment with l-DOPA and the nitric oxide donor, molsidomine","volume":"1541","author":"Czarnecka","year":"2013","journal-title":"Brain Res."},{"key":"10.1016\/j.nbd.2014.09.010_bb9000","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1111\/j.1460-9568.2008.06040.x","article-title":"Tyrosine hydroxylase cells appearing in the mouse striatum after dopamine denervation are likely to be projection neurones regulated by L-DOPA","volume":"27","author":"Darmopil","year":"2008","journal-title":"Eur. J. Neurosci."},{"key":"10.1016\/j.nbd.2014.09.010_bb0060","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1016\/j.biopsych.2009.04.025","article-title":"Genetic inactivation of dopamine D1 but not D2 receptors inhibits L-DOPA-induced dyskinesia and histone activation","volume":"66","author":"Darmopil","year":"2009","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.nbd.2014.09.010_bb0065","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1016\/S0896-6273(03)00568-3","article-title":"Parkinson's disease: mechanisms and models","volume":"39","author":"Dauer","year":"2003","journal-title":"Neuron"},{"key":"10.1016\/j.nbd.2014.09.010_bb0070","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1007\/s00213-002-1009-2","article-title":"Motor effects of acute and chronic inhibition of nitric oxide synthesis in mice","volume":"161","author":"Del Bel","year":"2002","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.nbd.2014.09.010_bb0075","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1007\/s10571-005-3065-8","article-title":"Role of nitric oxide on motor behavior","volume":"25","author":"Del Bel","year":"2005","journal-title":"Cell. Mol. Neurobiol."},{"key":"10.1016\/j.nbd.2014.09.010_bb0080","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1007\/s12640-013-9406-3","article-title":"Counteraction by nitric oxide synthase inhibitor of neurochemical alterations of dopaminergic system in 6-OHDA-lesioned rats under L-DOPA treatment","volume":"25","author":"Del-Bel","year":"2014","journal-title":"Neurotox. Res."},{"key":"10.1016\/j.nbd.2014.09.010_bb0085","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/0893-133X(95)00153-5","article-title":"7-Nitroindazole and methylene blue, inhibitors of neuronal nitric oxide synthase and NO-stimulated guanylate cyclase, block MK-801-elicited behaviors in mice","volume":"15","author":"Deutsch","year":"1996","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.nbd.2014.09.010_bb0090","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.nbd.2007.03.013","article-title":"Chronic 3,4-dihydroxyphenylalanine treatment induces dyskinesia in aphakia mice, a novel genetic model of Parkinson's disease","volume":"27","author":"Ding","year":"2007","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.nbd.2014.09.010_bb0095","doi-asserted-by":"crossref","first-page":"840","DOI":"10.1073\/pnas.1006511108","article-title":"Enhanced striatal cholinergic neuronal activity mediates L-DOPA-induced dyskinesia in parkinsonian mice","volume":"108","author":"Ding","year":"2011","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.nbd.2014.09.010_bb0100","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1016\/j.neulet.2011.03.087","article-title":"Differential expression of FosB, c-Fos, and Zif268 in forebrain regions after acute or chronic L-DOPA treatment in a rat model of Parkinson's disease","volume":"496","author":"Ebihara","year":"2011","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.nbd.2014.09.010_bb0105","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/j.nbd.2012.07.012","article-title":"L-DOPA-induced increase in TH-immunoreactive striatal neurons in parkinsonian mice: insights into regulation and function","volume":"48","author":"Espadas","year":"2012","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.nbd.2014.09.010_bb0110","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/S0169-328X(98)00259-9","article-title":"Basal ganglia neuronal nitric oxide synthase mRNA expression in Parkinson's disease","volume":"63","author":"Eve","year":"1998","journal-title":"Brain Res. Mol. Brain Res."},{"key":"10.1016\/j.nbd.2014.09.010_bb0115","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1007\/PL00005231","article-title":"The use of nitric oxide donors in pharmacological studies","volume":"358","author":"Feelisch","year":"1998","journal-title":"Naunyn Schmiedeberg's Arch. Pharmacol."},{"key":"10.1016\/j.nbd.2014.09.010_bb0120","article-title":"A role for mitogen- and stress-activated kinase 1 in L-DOPA-induced dyskinesia and \u0394FosB expression","author":"Feyder","year":"2014","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.nbd.2014.09.010_bb0125","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/B978-0-12-381328-2.00004-3","article-title":"Molecular mechanisms of l-DOPA-induced dyskinesia","volume":"98","author":"Fisone","year":"2011","journal-title":"Int. Rev. Neurobiol."},{"key":"10.1016\/j.nbd.2014.09.010_bb0130","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1016\/j.neurobiolaging.2007.08.014","article-title":"The transcription factor PITX3 is associated with sporadic Parkinson's disease","volume":"30","author":"Fuchs","year":"2009","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.nbd.2014.09.010_bb0140","doi-asserted-by":"crossref","first-page":"2783","DOI":"10.1111\/j.1460-9568.2008.06285.x","article-title":"Concepts of neural nitric oxide-mediated transmission","volume":"27","author":"Garthwaite","year":"2008","journal-title":"Eur. J. Neurosci."},{"key":"10.1016\/j.nbd.2014.09.010_bb0145","doi-asserted-by":"crossref","first-page":"1659","DOI":"10.1007\/s00702-011-0728-0","article-title":"Mechanisms underlying and medical management of L-Dopa-associated motor complications","volume":"118","author":"Gerlach","year":"2011","journal-title":"J. Neural Transm."},{"key":"10.1016\/j.nbd.2014.09.010_bb0150","doi-asserted-by":"crossref","first-page":"941","DOI":"10.1111\/j.1460-9568.2008.06387.x","article-title":"Lowered cAMP and cGMP signalling in the brain during levodopa-induced dyskinesias in hemiparkinsonian rats: new aspects in the pathogenetic mechanisms","volume":"28","author":"Giorgi","year":"2008","journal-title":"Eur. J. Neurosci."},{"key":"10.1016\/j.nbd.2014.09.010_bb0155","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1016\/j.nbd.2013.10.008","article-title":"Oleoylethanolamide reduces L-DOPA-induced dyskinesia via TRPV1 receptor in a mouse model of Parkinson's disease","volume":"62","author":"Gonz\u00e1lez-Aparicio","year":"2014","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.nbd.2014.09.010_bb0160","doi-asserted-by":"crossref","first-page":"1102","DOI":"10.1111\/j.1471-4159.2008.05705.x","article-title":"Persistent MDMA-induced dopaminergic neurotoxicity in the striatum and substantia nigra of mice","volume":"107","author":"Granado","year":"2008","journal-title":"J. Neurochem."},{"key":"10.1016\/j.nbd.2014.09.010_bb9005","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1016\/j.nbd.2011.01.033","article-title":"Dopamine D2-receptor knockout mice are protected against dopaminergic neurotoxicity induced by methamphetamine or MDMA","volume":"42","author":"Granado","year":"2011","journal-title":"Neurobiol Dis."},{"key":"10.1016\/j.nbd.2014.09.010_bb0165","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1124\/pr.111.005678","article-title":"The pharmacology of L-DOPA-induced dyskinesia in Parkinson's disease","volume":"65","author":"Huot","year":"2013","journal-title":"Pharmacol. Rev."},{"key":"10.1016\/j.nbd.2014.09.010_bb0170","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/S0169-328X(03)00162-1","article-title":"Selective loss of dopaminergic neurons in the substantia nigra of Pitx3-deficient aphakia mice","volume":"114","author":"Hwang","year":"2003","journal-title":"Brain Res. Mol. Brain Res."},{"key":"10.1016\/j.nbd.2014.09.010_bb0175","doi-asserted-by":"crossref","first-page":"2132","DOI":"10.1523\/JNEUROSCI.3718-04.2005","article-title":"3,4-dihydroxyphenylalanine reverses the motor deficits in Pitx3-deficient aphakia mice: behavioral characterization of a novel genetic model of Parkinson's disease","volume":"25","author":"Hwang","year":"2005","journal-title":"J. Neurosci."},{"key":"10.1016\/j.nbd.2014.09.010_bb0180","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.neuroscience.2012.03.023","article-title":"Animal models of L-DOPA-induced dyskinesia: an update on the current options","volume":"211","author":"Iderberg","year":"2012","journal-title":"Neuroscience"},{"key":"10.1016\/j.nbd.2014.09.010_bb0185","doi-asserted-by":"crossref","first-page":"1661","DOI":"10.1007\/s00702-011-0698-2","article-title":"Mechanisms underlying the onset and expression of levodopa-induced dyskinesia and their pharmacological manipulation","volume":"118","author":"Iravani","year":"2011","journal-title":"J. Neural Transm."},{"key":"10.1016\/j.nbd.2014.09.010_bb0190","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1016\/j.neulet.2006.03.064","article-title":"Effect of L-DOPA on nitric oxide production in striatum of freely mobile mice","volume":"402","author":"Itokawa","year":"2006","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.nbd.2014.09.010_bb0195","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1016\/S0022-3565(24)36836-3","article-title":"Modulation of cocaine- and methamphetamine-induced behavioral sensitization by inhibition of brain nitric oxide synthase","volume":"282","author":"Itzhak","year":"1997","journal-title":"J. Pharmacol. Exp. Ther."},{"issue":"Suppl. 11","key":"10.1016\/j.nbd.2014.09.010_bb0200","doi-asserted-by":"crossref","first-page":"S11","DOI":"10.1002\/mds.20458","article-title":"Motor fluctuations and dyskinesias in Parkinson's disease: clinical manifestations","volume":"20","author":"Jankovic","year":"2005","journal-title":"Mov. Disord."},{"key":"10.1016\/j.nbd.2014.09.010_bb0205","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1016\/j.expneurol.2004.10.002","article-title":"A simple rodent assay for the in vivo identification of agents with potential to reduce levodopa-induced dyskinesia in Parkinson's disease","volume":"191","author":"Johnston","year":"2005","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.nbd.2014.09.010_bb0210","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/S0166-2236(00)01745-8","article-title":"Nitric oxide: a novel link between synaptic and nonsynaptic transmission","volume":"24","author":"Kiss","year":"2001","journal-title":"Trends Neurosci."},{"key":"10.1016\/j.nbd.2014.09.010_bb0215","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/j.neuroscience.2012.12.065","article-title":"Parallel dopamine D1 receptor activity dependence of l-Dopa-induced normal movement and dyskinesia in mice","volume":"236","author":"Li","year":"2013","journal-title":"Neuroscience"},{"key":"10.1016\/j.nbd.2014.09.010_bb0220","doi-asserted-by":"crossref","first-page":"790","DOI":"10.1016\/j.neuint.2013.09.021","article-title":"Molsidomine, a nitric oxide donor, modulates rotational behavior and monoamine metabolism in 6-OHDA lesioned rats treated chronically with L-DOPA","volume":"63","author":"Lorenc-Koci","year":"2013","journal-title":"Neurochem. Int."},{"key":"10.1016\/j.nbd.2014.09.010_bb0225","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/j.expneurol.2005.02.002","article-title":"Pharmacological validation of a mouse model of l-DOPA-induced dyskinesia","volume":"194","author":"Lundblad","year":"2005","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.nbd.2014.09.010_bb0230","doi-asserted-by":"crossref","first-page":"3380","DOI":"10.1093\/brain\/awn235","article-title":"Combined 5-HT1A and 5-HT1B receptor agonists for the treatment of L-DOPA-induced dyskinesia","volume":"131","author":"Mu\u00f1oz","year":"2008","journal-title":"Brain"},{"key":"10.1016\/j.nbd.2014.09.010_bb0235","doi-asserted-by":"crossref","first-page":"51","DOI":"10.3389\/fnana.2011.00051","article-title":"Striatal signaling in L-DOPA-induced dyskinesia: common mechanisms with drug abuse and long term memory involving D1 dopamine receptor stimulation","volume":"5","author":"Murer","year":"2011","journal-title":"Front. Neuroanat."},{"key":"10.1016\/j.nbd.2014.09.010_bb0240","doi-asserted-by":"crossref","first-page":"1199","DOI":"10.1073\/pnas.0409138102","article-title":"Glutamate regulation of DARPP-32 phosphorylation in neostriatal neurons involves activation of multiple signaling cascades","volume":"102","author":"Nishi","year":"2005","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.nbd.2014.09.010_bb0245","doi-asserted-by":"crossref","first-page":"1047","DOI":"10.1590\/S0100-879X2010007500111","article-title":"Lack of tolerance for the anti-dyskinetic effects of 7-nitroindazole, a neuronal nitric oxide synthase inhibitor, in rats","volume":"43","author":"Novaretti","year":"2010","journal-title":"Braz. J. Med. Biol. Res."},{"key":"10.1016\/j.nbd.2014.09.010_bb0250","doi-asserted-by":"crossref","first-page":"4245","DOI":"10.1073\/pnas.0230529100","article-title":"Pitx3 is required for development of substantia nigra dopaminergic neurons","volume":"100","author":"Nunes","year":"2003","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.nbd.2014.09.010_bb0255","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/0014-2999(94)00742-P","article-title":"Nitric oxide synthase inhibitors block behavioral sensitization to methamphetamine in mice","volume":"275","author":"Ohno","year":"1995","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.nbd.2014.09.010_bb0260","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1016\/j.neuroscience.2009.01.034","article-title":"Nitric oxide synthase inhibition attenuates L-DOPA-induced dyskinesias in a rodent model of Parkinson's disease","volume":"159","author":"Padovan-Neto","year":"2009","journal-title":"Neuroscience"},{"key":"10.1016\/j.nbd.2014.09.010_bb0265","doi-asserted-by":"crossref","first-page":"40","DOI":"10.3389\/fnsys.2011.00040","article-title":"Nitric oxide synthase inhibitor improves de novo and long-term l-DOPA-induced dyskinesia in hemiparkinsonian rats","volume":"5","author":"Padovan-Neto","year":"2011","journal-title":"Front. Syst. Neurosci."},{"key":"10.1016\/j.nbd.2014.09.010_bb0270","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1016\/j.neulet.2013.02.015","article-title":"Anti-dyskinetic effect of the neuronal nitric oxide synthase inhibitor is linked to decrease of FosB\/deltaFosB expression","volume":"541","author":"Padovan-Neto","year":"2013","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.nbd.2014.09.010_bb0275","doi-asserted-by":"crossref","first-page":"1457","DOI":"10.1111\/j.1471-4159.2009.06416.x","article-title":"Regulation of striatal nitric oxide synthesis by local dopamine and glutamate interactions","volume":"111","author":"Park","year":"2009","journal-title":"J. Neurochem."},{"key":"10.1016\/j.nbd.2014.09.010_bb0280","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/j.biopsych.2005.05.044","article-title":"ERK phosphorylation and FosB expression are associated with L-DOPA-induced dyskinesia in hemiparkinsonian mice","volume":"59","author":"Pav\u00f3n","year":"2006","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.nbd.2014.09.010_bb0285","series-title":"The Mouse Brain in Stereotaxic Coordinates","author":"Paxinos","year":"2001"},{"key":"10.1016\/j.nbd.2014.09.010_bb0290","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1093\/brain\/awq342","article-title":"Inhibition of phosphodiesterases rescues striatal long-term depression and reduces levodopa-induced dyskinesia","volume":"134","author":"Picconi","year":"2011","journal-title":"Brain"},{"key":"10.1016\/j.nbd.2014.09.010_bb0295","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/B978-0-12-381328-2.00002-X","article-title":"l-Dopa-induced dyskinesia-clinical presentation, genetics, and treatment","volume":"98","author":"Prashanth","year":"2011","journal-title":"Int. Rev. Neurobiol."},{"key":"10.1016\/j.nbd.2014.09.010_bb0300","article-title":"Activation of DREAM (downstream regulatory element antagonistic modulator), a calcium-binding protein, reduces L-DOPA-induced dyskinesias in mice","author":"Ruiz-DeDiego","year":"2014","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.nbd.2014.09.010_bb0305","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1038\/sj.npp.1300826","article-title":"Phasic dopaminergic transmission increases NO efflux in the rat dorsal striatum via a neuronal NOS and a dopamine D(1\/5) receptor-dependent mechanism","volume":"31","author":"Sammut","year":"2006","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.nbd.2014.09.010_bb0310","doi-asserted-by":"crossref","first-page":"989","DOI":"10.1111\/j.1460-9568.2004.03566.x","article-title":"Down-regulation of nitrergic transmission in the rat striatum after chronic nigrostriatal deafferentation","volume":"20","author":"Sancesario","year":"2004","journal-title":"Eur. J. Neurosci."},{"key":"10.1016\/j.nbd.2014.09.010_bb0315","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/S0014-2999(02)01286-4","article-title":"Sodium nitroprusside stimulates L-DOPA release from striatal tissue through nitric oxide and cGMP","volume":"438","author":"Sanchez","year":"2002","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.nbd.2014.09.010_bb0320","doi-asserted-by":"crossref","first-page":"6995","DOI":"10.1523\/JNEUROSCI.0852-07.2007","article-title":"Critical involvement of cAMP\/DARPP-32 and extracellular signal-regulated protein kinase signaling in L-DOPA-induced dyskinesia","volume":"27","author":"Santini","year":"2007","journal-title":"J. Neurosci."},{"key":"10.1016\/j.nbd.2014.09.010_bb0325","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1111\/j.1471-4159.2008.05831.x","article-title":"L-DOPA activates ERK signaling and phosphorylates histone H3 in the striatonigral medium spiny neurons of hemiparkinsonian mice","volume":"108","author":"Santini","year":"2009","journal-title":"J. Neurochem."},{"key":"10.1016\/j.nbd.2014.09.010_bb0330","doi-asserted-by":"crossref","first-page":"e12322","DOI":"10.1371\/journal.pone.0012322","article-title":"Distinct changes in cAMP and extracellular signal-regulated protein kinase signalling in L-DOPA-induced dyskinesia","volume":"5","author":"Santini","year":"2010","journal-title":"PLoS One"},{"key":"10.1016\/j.nbd.2014.09.010_bb0335","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.tips.2008.10.005","article-title":"Neurobiology and treatment of Parkinson's disease","volume":"30","author":"Schapira","year":"2009","journal-title":"Trends Pharmacol. Sci."},{"key":"10.1016\/j.nbd.2014.09.010_bb0340","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1038\/nmeth.2089","article-title":"NIH Image to ImageJ: 25years of image analysis","volume":"9","author":"Schneider","year":"2012","journal-title":"Nat. Methods"},{"key":"10.1016\/j.nbd.2014.09.010_bb0345","doi-asserted-by":"crossref","first-page":"1145","DOI":"10.1242\/dev.01022","article-title":"Early developmental failure of substantia nigra dopamine neurons in mice lacking the homeodomain gene Pitx3","volume":"131","author":"Smidt","year":"2004","journal-title":"Development"},{"key":"10.1016\/j.nbd.2014.09.010_bb0350","doi-asserted-by":"crossref","first-page":"879","DOI":"10.1038\/nature06994","article-title":"A phosphatase cascade by which rewarding stimuli control nucleosomal response","volume":"453","author":"Stipanovich","year":"2008","journal-title":"Nature"},{"key":"10.1016\/j.nbd.2014.09.010_bb0355","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1016\/j.biopsych.2013.05.006","article-title":"L-DOPA treatment selectively restores spine density in dopamine receptor D2-expressing projection neurons in dyskinetic mice","volume":"75","author":"Su\u00e1rez","year":"2014","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.nbd.2014.09.010_bb0360","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1016\/j.ejphar.2012.03.008","article-title":"Neuronal nitric oxide synthase inhibition attenuates the development of L-DOPA-induced dyskinesia in hemi-Parkinsonian rats","volume":"683","author":"Takuma","year":"2012","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.nbd.2014.09.010_bb0365","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1038\/nrn2132","article-title":"Epigenetic regulation in psychiatric disorders","volume":"8","author":"Tsankova","year":"2007","journal-title":"Nat. Rev. Neurosci."},{"key":"10.1016\/j.nbd.2014.09.010_bb0370","doi-asserted-by":"crossref","first-page":"2535","DOI":"10.1242\/dev.00464","article-title":"Pitx3 is required for motor activity and for survival of a subset of midbrain dopaminergic neurons","volume":"130","author":"van den Munckhof","year":"2003","journal-title":"Development"},{"key":"10.1016\/j.nbd.2014.09.010_bb0375","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1111\/j.1471-4159.2005.03522.x","article-title":"Striatal neuroadaptation and rescue of locomotor deficit by L-dopa in aphakia mice, a model of Parkinson's disease","volume":"96","author":"van den Munckhof","year":"2006","journal-title":"J. Neurochem."},{"key":"10.1016\/j.nbd.2014.09.010_bb0380","doi-asserted-by":"crossref","first-page":"55","DOI":"10.3389\/fnsys.2011.00055","article-title":"Nitric oxide-soluble guanylyl cyclase-cyclic GMP signaling in the striatum: new targets for the treatment of Parkinson's disease?","volume":"5","author":"West","year":"2011","journal-title":"Front. Syst. Neurosci."},{"key":"10.1016\/j.nbd.2014.09.010_bb0385","doi-asserted-by":"crossref","first-page":"800","DOI":"10.1016\/j.biopsych.2006.11.032","article-title":"Spatiotemporal pattern of striatal ERK1\/2 phosphorylation in a rat model of L-DOPA-induced dyskinesia and the role of dopamine D1 receptors","volume":"62","author":"Westin","year":"2007","journal-title":"Biol. Psychiatry"}],"container-title":["Neurobiology of Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0969996114002824?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0969996114002824?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,5,4]],"date-time":"2025-05-04T23:08:14Z","timestamp":1746400094000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0969996114002824"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,1]]},"references-count":77,"alternative-id":["S0969996114002824"],"URL":"https:\/\/doi.org\/10.1016\/j.nbd.2014.09.010","relation":{},"ISSN":["0969-9961"],"issn-type":[{"value":"0969-9961","type":"print"}],"subject":[],"published":{"date-parts":[[2015,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Nitric oxide synthase inhibition decreases l-DOPA-induced dyskinesia and the expression of striatal molecular markers in Pitx3\u2212\/\u2212 aphakia mice","name":"articletitle","label":"Article Title"},{"value":"Neurobiology of Disease","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.nbd.2014.09.010","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}